Eclipse Regenesis, Inc.
1 clinical trials · Sponsor
◉ Watch Eclipse Regenesis, Inc.
| Record | Firm | Date |
|---|---|---|
| A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome (NCT05535361) | Eclipse Regenesis, Inc. | 2023-09-15 |
Track Eclipse Regenesis, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.